NYSE$ZBH

Zimmer Biomet Holdings Inc · Q4 2020 earnings

Q4 2020 earnings · · Investor relations

Briefing

Zimmer Biomet's Q4 2020 financial results were announced, revealing a slight decrease in net sales but a strong core business performance amidst COVID-19 pressures.

Zimmer Biomet reported Q4 net sales of $2.085 billion, a decrease of 1.9% compared to the prior year. Diluted earnings per share were $1.59, while adjusted diluted earnings per share were $2.11. The company also announced its intention to spin off its Spine and Dental businesses.

  • Fourth quarter net sales decreased by 1.9%, or 3.7% on a constant currency basis, reaching $2.085 billion.
  • Diluted earnings per share for the fourth quarter were $1.59, while adjusted diluted earnings per share amounted to $2.11.
  • Full-year net sales totaled $7.025 billion, representing a decrease of 12.0%, or 12.4% on a constant currency basis.
  • The company announced plans to spin off its Spine and Dental businesses to form a new, independent publicly traded company.

Headline financials

Total Revenue

$2.09B

Previous: $2.13B-1.9%
EPS (adj)

$2.11

Previous: $2.30-8.3%
Capital Expenditures

$27.7M

Previous: $51.8M-46.5%
Free Cash Flow

$329M

Previous: $295M+11.3%
Net Income

$334M

Previous: $321M+4.0%
Operating Income

$241M

Previous: $337M-28.5%
Gross Profit

$1.44B

Previous: $1.54B-6.8%
Cash & Equivalents

$802M

Previous: $618M+29.8%
Total Assets

$24.4B

Previous: $24.6B-0.9%
Stock-Based Comp

$17.7M

Previous: $22.7M-22.0%

Revenue & EPS history

Zimmer Biomet · Revenue · Quarterly

$2.09B

Q4 2020-1.9%vs Q4 2019
Beat estimate in 13 of 16 quarters(81%)
ActualEstimate

Revenue by segment

Zimmer Biomet · $1.62B total across 3 segments · Q4 2020

  • Knees Net Sales
    $737M-3.1%
  • Hips Net Sales
    $504M-1.4%
  • S.E.T. Net Sales
    $376M-20.6%

Forward guidance

Due to the uncertainty surrounding the ongoing impact of COVID-19, the Company is currently unable to quantify the expected impact on its results of operations, financial condition and cash flows for full year 2021 and is not providing financial guidance at this time.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2020

Historical avgQ4 2020

-0.4%

Avg return

Earnings day

-1.7%

Avg return

5 days after

-2.3%

Avg return

30 days after

42%

30 / 72 earnings

Positive

+11.9%

Q3 2020

Best reaction

-15.3%

Q3 2016

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.1%-10.5%-11.5%
Q4 2025+1.9%+7.5%+3.2%
Q3 2025-15.2%-14.0%-8.6%
Q1 2025-11.6%-7.0%-10.7%
Q4 2024-5.1%-8.6%-0.2%
Q3 2024+2.9%+4.4%+7.9%
Q2 2024-0.8%-2.3%-4.3%
Q1 2024+1.8%+1.6%-3.7%
Q4 2023-3.7%-3.4%-0.6%
Q3 2023-4.1%-3.5%+7.3%
Q2 2023-7.1%-8.6%-13.8%
Q1 2023+0.6%-0.7%-8.3%
Q4 2022+0.9%+2.6%-0.9%
Q3 2022-5.7%-3.9%+10.0%
Q2 2022+5.3%+3.2%-2.7%
Q1 2022+4.7%-0.3%+1.2%
Q4 2021-2.4%-5.4%-1.4%
Q3 2021-4.8%-9.7%-18.5%
Q2 2021-9.1%-8.6%-8.5%
Q1 2021-2.5%-3.1%-10.1%
Q4 2020-0.6%-0.2%-1.4%
Q3 2020+11.9%+7.2%+7.0%
Q2 2020-1.5%+2.7%+3.5%
Q1 2020-6.8%-7.8%+10.2%
Q4 2019+6.2%+5.3%-13.0%
Q3 2019+4.9%+5.5%+8.1%
Q2 2019+8.6%+9.1%+7.9%
Q1 2019-3.1%-2.8%-8.2%
Q4 2018+7.8%+7.9%+14.5%
Q3 2018-5.6%-7.0%-7.7%
Q2 2018+8.0%+7.1%+7.1%
Q1 2018+5.7%+5.8%+0.4%
Q4 2017-0.2%-1.3%-10.9%
Q3 2017-7.7%-10.1%-5.8%
Q2 2017-3.8%-6.5%-12.1%
Q1 2017-4.5%-3.7%-4.9%
Q4 2016+2.7%+2.4%+2.3%
Q3 2016-15.3%-15.9%-16.9%
Q2 2016+6.9%+6.4%+5.6%
Q1 2016-0.1%
Q4 2015-2.3%
Q3 2015+6.8%
Q2 2015-2.7%
Q1 2015-4.3%
Q4 2014-2.1%
Q3 2014+5.1%
Q2 2014-2.3%
Q1 2014+9.9%
Q4 2013+0.8%
Q3 2013-3.3%
Q2 2013+0.5%
Q1 2013+0.6%
Q4 2012-1.3%
Q3 2012+2.0%
Q2 2012-3.5%
Q1 2012-0.6%
Q4 2011-1.3%
Q3 2011+3.7%
Q2 2011-5.6%
Q1 2011+0.5%
Q4 2010+2.2%
Q3 2010+3.6%
Q2 2010-1.5%
Q1 2009-0.8%
Q1 2010+1.6%
Q4 2009-0.2%
Q3 2009+4.0%
Q3 2008+4.0%
Q4 2007-1.0%
Q2 2008-1.0%
Q2 2009-1.0%
Q4 2008-1.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro